Campbell & Co. Investment Adviser »

Cytokinetics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.1M 97k 63.54
2023-09-30 $830k 28k 29.46
2023-06-30 $456k 14k 32.62
2022-06-30 $799k 20k 39.31
2019-03-31 $355k 44k 8.10
2016-12-31 $128k 11k 12.19

More positions owned by Campbell & Co. Investment Adviser

Itt Common Stock (ITT)
Cheniere Energy Common Stock (LNG)
United Rentals Common Stock (URI)
BHP Group Adr (BHP)
Cullen/Frost Bankers Common Stock (CFR)
Pool Corp Common Stock (POOL)
Ameris Bancorp Common Stock (ABCB)
Bank of America Corp Common Stock (BAC)
Aecom Common Stock (ACM)
Associated Banc-Corp Common Stock (ASB)
DTE Energy Common Stock (DTE)
Netflix Common Stock (NFLX)
Allstate Corp/The Common Stock (ALL)
Labcorp Holdings Common Stock (LH)
Southwest Airlines Common Stock (LUV)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
State Street Corporation
Deep Track Capital
Geode Capital Management
Susquehanna International
Rtw Investments
Goldman Sachs Group
Polar Capital Holdings
Armistice Capital
Integral Health Asset Management
Citadel Advisors

View all funds holding Cytokinetics